Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, October 2000, p. 2853-2854, Vol. 44, No. 10
Department of Microbiology, Tohoku
Pharmaceutical University, Sendai 981-8558,1 and
General Education Department, Kogakuin University, Hachioji,
Tokyo 192-0015,2 Japan
Received 3 March 2000/Returned for modification 30 March
2000/Accepted 28 June 2000
A new platinum derivative of the form
H[Pt(IV)(Hdigly)Cl2(OH)2]
(Hdigly==glycylglycine) damaged the Candida albicans cell
membrane and inhibited the growth of the cells. The cytotoxic activity of H[Pt(IV)(Hdigly)Cl2(OH)2] on mammalian
cells was 10-fold lower than that of
cis-diammine-dichloroplatinum (cisplatin). Substitution of
platinum for peptides is effective for enhancement of antifungal activity and reduction of the toxicity to mammalian cells.
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Anti-Candida Activity of a New
Platinum Derivative
*
Corresponding author. Mailing address: Department of
Microbiology, Tohoku Pharmaceutical University, Sendai 981-8558, Japan. Phone: (81 22) 234 4181. Fax: (81 22) 275 2013. E-mail:
tmatsu{at}tohoku-pharm.ac.jp.
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |